YTL Corporation Berhad (KLSE:YTL)

Sage Therapeutics Ratios and Metrics

Market cap in millions MYR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	29,220	37,965	11,403	6,414	7,181	8,839
Market Cap Growth	-23.38%	232.95%	77.78%	-10.69%	-18.76%	-25.32%
Enterprise Value	71,132	75,771	47,627	40,625	42,101	48,498
PE Ratio	15.37	17.74	10.41	9.23	-	-
PS Ratio	0.93	1.25	0.39	0.27	0.42	0.46
PB Ratio	1.19	1.57	0.57	0.36	0.44	0.57
P/FCF Ratio	40.63	14.20	4.40	-	6.53	6.04
P/OCF Ratio	4.79	5.96	2.44	4.15	2.39	2.91
EV/Sales Ratio	2.27	2.49	1.61	1.68	2.44	2.53
EV/EBITDA Ratio	7.78	8.70	7.60	9.42	12.26	13.56
EV/EBIT Ratio	10.35	10.75	10.27	15.06	23.69	24.17
EV/FCF Ratio	98.91	28.34	18.37	-	38.29	33.15
Debt / Equity Ratio	2.27	2.01	2.38	2.45	2.85	2.90
Debt / EBITDA Ratio	6.44	5.45	7.39	9.71	12.87	11.99
Debt / FCF Ratio	77.32	18.18	18.44	-	42.35	30.89
Quick Ratio	1.77	1.51	1.46	1.35	1.31	1.10
Current Ratio	1.89	1.69	1.59	1.55	1.45	1.28
Asset Turnover	0.35	0.36	0.38	0.33	0.24	0.26
Return on Equity (ROE)	14.74%	17.55%	11.20%	8.49%	-2.05%	0.03%
Return on Assets (ROA)	4.42%	5.17%	3.75%	2.30%	1.54%	1.71%
Return on Capital (ROIC)	5.31%	6.26%	4.48%	2.71%	1.80%	1.96%
Return on Capital Employed (ROCE)	8.00%	9.60%	7.00%	4.50%	3.00%	3.70%
Earnings Yield	6.39%	5.64%	9.61%	10.84%	-5.12%	-2.14%
Earnings Yield	6.39%	5.64%	9.61%	10.84%	-5.12%	-2.14%
FCF Yield	2.46%	7.04%	22.73%	-5.65%	15.31%	16.55%
Dividend Yield	1.79%	1.33%	4.04%	5.68%	4.40%	-
Payout Ratio	26.62%	20.49%	30.02%	39.43%	-	-
Buyback Yield / Dilution	-0.35%	-1.42%	-0.07%	-1.42%	-2.02%	-0.75%
Total Shareholder Return	1.47%	-0.08%	3.97%	4.26%	2.38%	-0.75%

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.